2025 Kent & Medway Medicines Optimisation Newsletters
Kent and Medway Medicines Optimisation Newsletters For 2025
Kent & Medway Medicines Optimisation team produce a monthly newsletter highlighting prescribing information together with local and national health information.
You can view or download copies of our newsletters
| Issue | Date | Article |
| Issue 69 Click Here | March 2025 | • Update on the implementation of The National Institute for Health and Care Excellence (NICE) technology appraisal TA 1026: Tirzepatide for managing overweight and obesity • Kent and Medway ICB response to National Patient Safety Alert for PERT • Buspirone prescribing in primary care • Asthma + Lung UKs Winter Help Guide • MHRA Valproate Guidance: Ensuring Safe Prescribing and Risk Minimisation • MHRA Update • Shortages Summary |
| Issue 68 Click Here | Feb 2025 | • SPS Webinar- MSATS: Safer Use of Insulin- Wednesday 26th March 12:30pm-14:00pm • Supplies of GLP-1 RAs • Discontinuation of FreeStyle Libre 2 – Transition to FreeStyle Libre 2 Plus • Vaccination Training Opportunities- Building Skills and Knowledge • Aerobika mucus clearance device prescribing in primary care • Tissue Viability training sessions March 2025 • Safety considerations with Urospir: First licensed spironolactone oral solution • Polypharmacy Masterclasses: Health Innovation Network • Kent and Medway List of New Approved Guidelines from Integrated Medicines Optimisation Committee (IMOC) January 2025 • Valproate Drug Safety Update • MHRA Drug Safety Update • Shortages Update • NICE News |
| Issue 66 Click Here | Dec 24/ Jan 2025 | • Reminder - Registering for MHRA Safety Alerts • ADHD Medication Supply Disruption Update – November 2024 • TARGET webinars • Varenicline (Champix) • National Changes to Community Pharmacy Dispensing Regulations: Original Pack Dispensing • MHRA Drug Safety Update – November 2024 • Nice news • Shortages Summary • Shortage of Quetiapine modified release tablets, (Biquelle XL and Brancico XL) • Shortage of Fiasp (insulin aspart) FlexTouch 100units/ml solution for injection 3ml pre-filled pens • Shortage of Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled pens • Discontinuation of Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges • Discontinuation of saxagliptin/metformin (Komboglyze) 2.5mg/1000mg tablets |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only